Prevention · Harm Reduction · For people who inject, and the people who love them

Syringe services programs — one of the most effective HIV-prevention tools we have.

Last reviewed: September 2026

Educational information only — not medical advice. Talk to your healthcare provider about your specific situation.

SSPs (syringe services programs, also called syringe exchange or needle exchange) provide sterile syringes, safe disposal, naloxone, HIV and hepatitis C testing, wound care, and links to treatment — without judgment and without requiring you to stop using. The CDC, NIH, and 30 years of research all support them. This page explains how they work, where to find one, and what the law looks like where you live.

CDC guidance · NASEN locator · State-by-state legal status
Share Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky
← Home

Start here

The short version: Syringe services programs are one of the most rigorously studied HIV-prevention interventions in public health. The CDC says explicitly that SSPs do not increase drug use, do not increase crime, and substantially reduce HIV and hepatitis C transmission — while dramatically increasing entry into treatment for people who want it.1 They also distribute naloxone, do wound care, test for HIV and hepatitis C, and refer to PrEP, ART, buprenorphine, and methadone.

A New Haven study cited by CDC found new-user HIV incidence dropped by an estimated 33% after that city's SSP launched. Multiple systematic reviews since have confirmed the pattern. People who use SSPs are five times more likely to enter substance-use treatment than those who don't.2

You do not need to be sober, in treatment, or ready to quit to use an SSP. That is the point. This page is written for you if you inject, know someone who does, or want to volunteer or donate to a local SSP.

What syringe services programs actually do

The evidence — three decades of research

~50%
Reduction in HIV incidence associated with SSP access (multiple systematic reviews)
Higher likelihood of entering substance-use treatment among SSP users
$3-$7
Public-health return per $1 invested in SSPs (CDC cost-effectiveness analyses)
CDC position

SSPs are "safe, effective, and cost-saving"

Since the mid-2000s CDC has held a consistent evidence-based position: SSPs prevent HIV and hepatitis C transmission, do not increase illegal drug use, do not increase crime, and are one of the most cost-effective HIV interventions in the U.S. public-health toolkit.1

NIH / NIDA

Federal research consensus since the 1990s

Every major federal review since a 1997 Institute of Medicine report has concluded that SSPs reduce HIV transmission without increasing drug use. NIH-funded studies through the National Institute on Drug Abuse (NIDA) continue to build on this.3

Real-world case study

The 2015 Scott County, Indiana outbreak

Scott County had banned SSPs. When the fentanyl-era HIV outbreak hit rural Indiana in 2014-2015, the state was forced to authorize an emergency SSP. HIV transmission dropped. Governor Mike Pence, who had opposed SSPs on ideological grounds, later credited the SSP for controlling the outbreak. This became the reference case for rural HIV outbreak preparedness.4

How to find an SSP near you

Florida — the local picture

Florida legalized SSPs statewide in 2019 through the Miguel Gomez Prevention Act, extending authorization first piloted in Miami-Dade County under the University of Miami's IDEA Exchange starting in 2016. Programs must be approved by their county government; several Florida counties have active SSPs. Sterile syringes are legal to possess when obtained from a licensed SSP.5

Your first visit — what to expect

You do not need ID. You do not need to give your real name (though most SSPs use a first-name-only ID system so they can track your services). You do not need insurance. You do not need to be ready to quit. You will not be asked to.

  1. Walk in or find the mobile unit. Hours vary; check the locator or call ahead.
  2. Get sterile supplies. Syringes, cookers, cotton, sterile water, alcohol pads, tourniquets, and safe-disposal container. Some programs also do 1:1 exchange; some don't require exchange at all.
  3. Get naloxone. Two doses of Narcan (or generic) plus a 5-minute training. Take extras for your friends.
  4. Say yes or no to testing. HIV and hep C rapid testing is optional. It is anonymous and free.
  5. Ask about anything. Wound care. Bad batches in the local supply. PrEP. MOUD (medication for opioid use disorder). Housing. Legal help. SSP staff know their local resource landscape.
  6. Come back. The relationship is the point. Consistent contact with an SSP is one of the strongest predictors of entering treatment when someone is ready.
"Nobody gets sober while dead. And nobody makes clear decisions about their life without a place to be safe. Syringe services programs are how public health finally learned that lesson." — Community harm-reduction leaders, paraphrased in NASEN materials

Questions people ask

Isn't giving out syringes just enabling drug use?

Decades of research and every major public-health body say no. SSPs do not increase drug use. They do reduce HIV and hepatitis C transmission, reduce overdose deaths through naloxone distribution, and connect people to treatment. The evidence is exceptionally consistent across countries.

Is it legal to carry syringes if I got them from an SSP?

In most U.S. states now, yes — but paraphernalia laws vary. Ask your local SSP; they know the specific answer for your county. Some SSPs provide ID cards documenting participation.

Will the SSP report me to the police?

No. SSPs are confidential health services. They do not share information with law enforcement.

Can I go to an SSP even if I use snorting or smoking rather than injecting?

Yes. Most SSPs distribute safer smoking and snorting supplies alongside injection supplies. They also do fentanyl test strips and naloxone regardless of route.

What if I'm HIV-positive already and use drugs?

SSPs are a strong partner for you. ART adherence, viral suppression, opioid-use-disorder treatment, and mental-health care can all be coordinated through a good SSP or its referral network. See substance use & HIV.

Related on RiseUpToHIV

References & Sources

CDC, NIH/NIDA, NASEN, Florida Department of Health, peer-reviewed research on SSPs.

  1. CDC. Syringe Services Programs (SSPs) Fact Sheet. Official CDC position and evidence base. cdc.gov — SSP fact sheet
  2. CDC. Syringe Services Programs: Summary of Evidence. Includes New Haven, Baltimore, and multi-city data. cdc.gov — evidence summary
  3. National Institute on Drug Abuse (NIDA). Syringe Services Programs. Research summary. nida.nih.gov — NIDA on SSPs
  4. CDC MMWR. Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015. cdc.gov — Scott County outbreak MMWR
  5. Florida Department of Health. Miguel Gomez Prevention Act — SSP authorization. floridahealth.gov — Florida SSP authority
  6. North American Syringe Exchange Network (NASEN). SSP directory and resources. nasen.org — national directory
  7. NEXT Distro. Mail-based harm reduction supplies and naloxone. nextdistro.org — mail-order supplies
  8. SAMHSA. Find substance-use treatment. findtreatment.gov — national locator
  9. IDEA Exchange, University of Miami. Florida's first legal SSP. ideaexchangeflorida.org — Miami-Dade SSP